Related references
Note: Only part of the references are listed.MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer (vol 285, pg 17869, 2010)
William Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
V. Y. Shin et al.
BRITISH JOURNAL OF CANCER (2015)
Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
Isabel Stückrath et al.
Oncotarget (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
Alessandra Mangolini et al.
BIOMARKER RESEARCH (2015)
Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
Marek Sochor et al.
BMC CANCER (2014)
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors
Andliena Tahiri et al.
CARCINOGENESIS (2014)
Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer
Fu-long Zhao et al.
MOLECULAR BIOLOGY REPORTS (2014)
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
Annette R. Kodahl et al.
MOLECULAR ONCOLOGY (2014)
MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer
Qifeng Luo et al.
ONCOLOGY REPORTS (2014)
High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer
Simone Anfossi et al.
PLOS ONE (2014)
Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
Ailbhe M. McDermott et al.
PLOS ONE (2014)
MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
Mao Ouyang et al.
PLOS ONE (2014)
Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p
Carlos Marino Cabral Calvano Filho et al.
TUMOR BIOLOGY (2014)
MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells
Guoqiang Zhang et al.
TUMOR BIOLOGY (2014)
Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer
In Hae Park et al.
TUMOR BIOLOGY (2014)
Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status
Lene Rask et al.
CELLULAR ONCOLOGY (2014)
Identification of Circulating MicroRNA Signatures for Breast Cancer Detection
Maurice Chan et al.
CLINICAL CANCER RESEARCH (2013)
Serum circulating microRNA profiling for identification of potential breast cancer biomarkers
Fermin Mar-Aguilar et al.
DISEASE MARKERS (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressiveness
Florence Lerebours et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Absolute quantification by droplet digital PCR versus analog real-time PCR
Christopher M. Hindson et al.
NATURE METHODS (2013)
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Enders K. O. Ng et al.
PLOS ONE (2013)
Identification and Validation of miRNAs as Endogenous Controls for RQ-PCR in Blood Specimens for Breast Cancer Studies
Ailbhe M. McDermott et al.
PLOS ONE (2013)
Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients
Jingjing Liu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2013)
Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort
Ashley C. Godfrey et al.
BREAST CANCER RESEARCH (2013)
Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls
Zhibin Hu et al.
CARCINOGENESIS (2012)
Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
Dharanija Madhavan et al.
CLINICAL CANCER RESEARCH (2012)
Impact of microRNA regulation on variation in human gene expression
Jian Lu et al.
GENOME RESEARCH (2012)
Decreased serum miR-181a is a potential new tool for breast cancer screening
Li-Juan Guo et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Ke Zen et al.
MEDICINAL RESEARCH REVIEWS (2012)
Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
Michael G. Schrauder et al.
PLOS ONE (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
Dan Li et al.
CLINICAL CANCER RESEARCH (2011)
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Helen M. Heneghan et al.
ANNALS OF SURGERY (2010)
Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease
Helen M. Heneghan et al.
ONCOLOGIST (2010)
MicroRNAs as Novel Biomarkers for Breast Cancer
H. M. Heneghan et al.
JOURNAL OF ONCOLOGY (2010)
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
E. K. O. Ng et al.
GUT (2009)
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder
Ryan M. O'Connell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth
Xiaohong Wang et al.
PLOS ONE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Madhu S. Kumar et al.
NATURE GENETICS (2007)
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
Therese Sorlie et al.
BMC GENOMICS (2006)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
N Yanaihara et al.
CANCER CELL (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
J Kluiver et al.
JOURNAL OF PATHOLOGY (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Principle and applications of digital PCR
G Pohl et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2004)
Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR -: art. no. e36
MW Pfaffl et al.
NUCLEIC ACIDS RESEARCH (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Validities of mRNA quantification using recombinant RNA and recombinant DNA external calibration curves in real-time RT-PCR
MW Pfaffl et al.
BIOTECHNOLOGY LETTERS (2001)
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
SA Bustin
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA
C Mannhalter et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2000)
Share Paper
